Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights
MENLO PARK, Calif. , Nov. 16, 2017 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results for the fourth…